LLY Feb 2025 500.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 10:38AM EDT
Loading interactive chart…
- Simply Wall St.
Boasting A 54% Return On Equity, Is Eli Lilly and Company (NYSE:LLY) A Top Quality Stock?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Insider Monkey
Eli Lilly and Company (LLY): Among the Most Promising Growth Stocks According to Hedge Funds
We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other Most Promising Growth Stock According to Hedge Funds. Bull Market and Investor Sentiment Investors had been anxiously anticipating the start […]
- GuruFocus.com
Eli Lilly Expects Zepbound Approval in Japan by Mid-2025, Eyes Weight-Loss Market
Eli Lilly anticipates regulatory approval for its weight-loss drug Zepbound in Japan by mid-2025, boosting its global portfolio
© 2024 Yahoo. All rights reserved.